How did the AstraZeneca-Oxford Covid-19 vaccine go from ‘game changer’ to ‘under review’?

• Safety concerns about rare blood clots and controversy over slow deliveries threaten to derail the roll-out of the vaccine in many countries
• Medical experts say it is important that all potential risks are reported, but they worry that the negative attention could shatter public confidence in Covid-19 inoculations